Neuroprotection in experimental stroke with targeted neurotrophins.
about
Neuroprotection for ischemic stroke: past, present and futurePotential therapeutic effects of neurotrophins for acute and chronic neurological diseasesPharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersDerivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured ratAlpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.Microglial involvement in neuroplastic changes following focal brain ischemia in rats.Non-Coding RNAs as Potential Neuroprotectants against Ischemic Brain Injury.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionCell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro.A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variantsFear extinction and BDNF: translating animal models of PTSD to the clinic.Growth factors and stroke.Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders.Rac1 is a critical mediator of endothelium-derived neurotrophic activity.Beta-amyloid toxicity and reversal in embryonic rat septal neurons.Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in ratsMechanisms and targets for angiogenic therapy after stroke.Fibroblast growth factors in schizophrenia.Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.Beta-amyloid toxicity in embryonic rat astrocytes.Fibroblast growth factors in neurodevelopment and psychopathology.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Growth factor conjugation: strategies and applications.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Phytochemicals in Ischemic Stroke.Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder.Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.A Novel Cell Therapy Method for Recovering after Brain Stroke in Rats.Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS.Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemiaLipoic acid and bone marrow derived cells therapy induce angiogenesis and cell proliferation after focal brain injury.Intense training overcomes effects of the Val66Met BDNF polymorphism on short-term plasticity.Targeting the reconsolidation of extinction memories: a novel potential strategy to treat anxiety disorders.Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin.Activation of expression of brain-derived neurotrophic factor at the site of implantation of allogenic and xenogenic neural stem (progenitor) cells in rats with ischemic cortical stroke.bFGF plays a neuroprotective role by suppressing excessive autophagy and apoptosis after transient global cerebral ischemia in rats.
P2860
Q24645185-E5F08A80-F119-4A15-928A-018A78DCE3BEQ26827281-A1212191-69D4-4309-9B69-BC7D310290ECQ27006437-52CC1771-4F67-4AF7-BAB1-0CF72C53D612Q27324122-C0B46E0A-583F-4B84-9B1D-FB7D5C3BAFBEQ28085176-4A9FE688-DBFE-4D73-B5C7-CC49049830EEQ30487878-28D8BC52-BF85-48F3-83DA-FE2133FFF8C4Q30940972-FFD24FFB-04F8-4611-A905-95B01D23106CQ33772089-7DC4CF13-3395-4D0C-B57D-34ECB0CE0D09Q34088803-566F031F-6076-41F1-9E2D-398181B001EAQ34578270-7992D8A5-589B-42F5-A6FD-D1F9F890B672Q34815480-1C7423C7-4DFA-44CF-8D00-726FC2BD69D3Q35195927-8BDDEC5A-E23E-4E92-B743-E3B05DAF9187Q35878417-BF93D25A-CA75-4D46-A2E9-78B0BA33DB53Q36074354-7A698A80-0AD7-4DF6-BF5A-D9252889B69CQ36608807-5FD48B3E-CCBD-4371-9006-E5DE872354D7Q36871981-1C0B8267-9121-4075-B4B2-AD6D8B0CF97AQ37157708-DC51A6CD-FCA0-4BE6-B2FC-C7A56773946BQ37362146-221ECAD7-BC2C-40B1-A906-E5C59A537157Q37397855-0BCB0FA8-3313-44A7-9836-56ACCEEA6055Q37442498-A739C127-AF13-42AB-AB8D-05E29508C9D1Q37476441-B981E50B-70C8-49C8-A87C-01A45EBB3D9FQ37584887-837C7644-DF3B-463D-B9C9-7FA44ABF0972Q37592514-D873DC7E-8F0A-4C9B-8070-0AD24BC3C6A0Q38076267-A899AC23-76FD-449B-97BE-94A3DD53BC6EQ38116765-D434FD5A-8981-4B9B-9CDC-9372F7167A08Q38168376-66E7CADD-D005-494A-9024-E85C5F84E092Q38204731-FC13F51A-D14E-4925-88DF-8601FC6087A4Q38587566-B3FDEC27-6D4E-4577-A6C6-0D22C94BC043Q38837831-69B8AD01-2FB1-438E-AADB-D40B245C8B3DQ39005149-0A960145-9547-4FBB-8136-FE00FCA61CF2Q40292313-72B881B7-1B07-4C99-9BD5-08FF863484A0Q41826915-6E56D747-288F-4CC0-86A4-DDB92586DFB1Q41864443-254B93DD-E52D-4F36-87D0-69F161E56A2CQ42587600-FA347F9E-D52A-4CBF-B6F4-F5675ED28F81Q45036156-64446D48-DF49-4C9F-B77A-6DD9E7EA3476Q46335749-75CBDEDE-8406-444F-B390-A1E55020B3C2Q47646548-1FB7EB99-49B7-472D-B57E-0247201AD8E9Q48591169-003D07CF-C9A8-450B-AD75-208C5578E4AAQ48696877-ED3FC9DA-4A79-4EB5-992F-F934BEFE205FQ50130030-402DA6E5-AEE7-490D-9696-EE23F95CB022
P2860
Neuroprotection in experimental stroke with targeted neurotrophins.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Neuroprotection in experimental stroke with targeted neurotrophins.
@ast
Neuroprotection in experimental stroke with targeted neurotrophins.
@en
Neuroprotection in experimental stroke with targeted neurotrophins.
@nl
type
label
Neuroprotection in experimental stroke with targeted neurotrophins.
@ast
Neuroprotection in experimental stroke with targeted neurotrophins.
@en
Neuroprotection in experimental stroke with targeted neurotrophins.
@nl
prefLabel
Neuroprotection in experimental stroke with targeted neurotrophins.
@ast
Neuroprotection in experimental stroke with targeted neurotrophins.
@en
Neuroprotection in experimental stroke with targeted neurotrophins.
@nl
P2860
P356
P1433
P1476
Neuroprotection in experimental stroke with targeted neurotrophins.
@en
P2093
P2860
P304
P356
10.1602/NEURORX.2.1.120
P577
2005-01-01T00:00:00Z